Stockscreener 앱 받기
1.185
9.17%
0.095
전일 마감가:
$1.09
열려 있는:
$1.11
하루 거래량:
461.08K
Relative Volume:
0.96
시가총액:
$43.79M
수익:
-
순이익/손실:
$-9.16M
주가수익비율:
-2.0789
EPS:
-0.57
순현금흐름:
$-8.75M
1주 성능:
-1.65%
1개월 성능:
-6.30%
6개월 성능:
+32.22%
1년 성능:
+20.19%
1일 변동 폭
$1.10
$1.195
1주일 범위
$1.05
$1.21
52주 변동 폭
$0.75
$1.6899
Renovorx Inc Stock (RNXT) Company Profile
명칭
Renovorx Inc
전화
408-800-2649
주소
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
RNXT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RNXT
Renovorx Inc
|
1.195 | 39.94M | 0 | -9.16M | -8.75M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
411.74 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.05 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.08 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
816.00 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Renovorx Inc 주식(RNXT)의 최신 뉴스
Has RenovoRx Inc. formed a bullish divergenceQuarterly Investment Review & Reliable Breakout Forecasts - newser.com
What does recent volatility data suggest for RenovoRx Inc.Market Trend Summary & High Accuracy Swing Trade Signals - newser.com
Evaluating RenovoRx Inc. with trendline analysisPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Relative strength of RenovoRx Inc. in sector analysisQuarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Is RenovoRx Inc. stock reversal real or fakeJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
RenovoRx : Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD - MarketScreener
Is RenovoRx Inc. stock entering bullish territory2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
Is RenovoRx Inc. reversing from oversold territoryJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
Identifying reversal signals in RenovoRx Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
RenovoRx Inc. stock chart pattern explainedMarket Weekly Review & Step-by-Step Trade Execution Guides - newser.com
Is RenovoRx Inc. forming a bottoming baseEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Will RenovoRx Inc. stock outperform Dow Jones indexAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
RenovoRx adds interventional oncology expert to scientific advisory board By Investing.com - Investing.com Nigeria
RenovoRx’s Earnings Call: Positive Outlook Amid Growth - MSN
RenovoRx adds interventional oncology expert to scientific advisory board - Investing.com
RenovoRx Appoints Renowned Oncologist Thierry de Baère, MD, PhD, to Scientific Advisory Board - Quiver Quantitative
400+ publications & 22,000 citations: RenovoRx appoints Thierry de Baère to Scientific Advisory Board - Stock Titan
Will RenovoRx Inc. outperform the marketMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
Will earnings trigger a reversal in RenovoRx Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Forecasting RenovoRx Inc. price range with options data2025 Investor Takeaways & Weekly Momentum Picks - newser.com
RenovoRx : Corporate Overview - MarketScreener
Custom strategy builders for tracking RenovoRx Inc.2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Developing predictive dashboards with RenovoRx Inc. dataEarnings Overview Report & Long-Term Growth Portfolio Plans - newser.com
How institutional ownership impacts RenovoRx Inc. stock2025 Short Interest & Fast Gaining Stock Reports - newser.com
RenovoRx prices public offering to raise $12.1M - MSN
Comparing Annovis Bio (NYSE:ANVS) & RenovoRx (NASDAQ:RNXT) - Defense World
RenovoRx (NASDAQ:RNXT) Trading Up 7.6% – Here’s What Happened - Defense World
What analysts say about RenovoRx Inc stockCurrency Fluctuation Impact & Register for the Next Free Workshop - earlytimes.in
RenovoRx Inc Stock Analysis and ForecastTechnical Pattern Recognition & Budget Friendly Portfolio Growth - earlytimes.in
Renovorx Inc (RNXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Renovorx Inc 주식 (RNXT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bagai Shaun | Chief Executive Officer |
Aug 25 '25 |
Buy |
0.91 |
5,000 |
4,549 |
330,040 |
| Agah Ramtin | Chief Medical Officer |
Jun 05 '25 |
Buy |
1.40 |
21,000 |
29,400 |
734,460 |
| Marton Laurence | Director |
May 02 '25 |
Option Exercise |
0.15 |
20,480 |
3,072 |
66,164 |
| Agah Ramtin | Chief Medical Officer |
Apr 15 '25 |
Buy |
0.90 |
15,000 |
13,500 |
1,113,460 |
| Bagai Shaun | Chief Executive Officer |
Apr 15 '25 |
Buy |
0.91 |
7,500 |
6,821 |
320,040 |
| Agah Ramtin | Chief Medical Officer |
Apr 11 '25 |
Buy |
0.80 |
20,000 |
16,000 |
1,098,460 |
| Kocak Ron | VP Controller and PAO |
Apr 10 '25 |
Buy |
0.79 |
6,500 |
5,135 |
12,595 |
| Kocak Ron | VP Controller and PAO |
Apr 09 '25 |
Buy |
0.80 |
6,000 |
4,800 |
6,095 |
| Kocak Ron | VP Controller and PAO |
Apr 08 '25 |
Buy |
0.80 |
95 |
76 |
95 |
| Agah Ramtin | Chief Medical Officer |
Apr 09 '25 |
Buy |
0.81 |
30,000 |
24,399 |
1,078,460 |
5.39%
1.24%
자본화:
|
볼륨(24시간):